D

Avricore Health Inc. AVCRF

$0.00 -$0.02-96.80% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Avricore Health Inc. is a Canadian health technology and diagnostics company focused on point-of-care testing, data connectivity, and pharmacy-based health screening solutions. The company operates primarily in the healthcare technology and diagnostic services industries, with a business model centered on delivering rapid screening systems that connect patients, pharmacies, and healthcare providers through real-time health data platforms. Its core revenue drivers have included diagnostic testing services, technology platform deployment, and commercialization partnerships tied to pharmacy networks and healthcare providers.

The company is best known for its HealthTab™ platform, which enables community pharmacies and healthcare locations to conduct point-of-care blood testing and health assessments using connected diagnostic devices. Avricore Health has positioned itself around decentralized healthcare delivery and preventative screening, particularly in chronic disease management and cardiovascular risk assessment. The company evolved from earlier healthcare technology and wellness initiatives into a diagnostics-focused platform business, expanding its pharmacy-centered testing model across Canada through strategic commercial relationships and technology integration initiatives.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Tuesday, September 1, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Beginning of December (est)

Price History

Loading...
52-Week Range0% of range
Low
$0.00
Current
$0.00
High
$0.08
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
778 968 1176
Address
700 – 1199 West Hastings Street
Vancouver, BC V6E 3T5
Country
Year Founded

Headlines

There are no news to display.